General Assembly Raised Bill No. 933
January Session, 2015 LCO No. 3589
*03589_______GL_*
Referred to Committee on GENERAL LAW
Introduced by:
(GL)
General Assembly
Raised Bill No. 933
January Session, 2015
LCO No. 3589
*03589_______GL_*
Referred to Committee on GENERAL LAW
Introduced by:
(GL)
AN ACT CONCERNING THE PRESCRIPTION DRUG MONITORING PROGRAM.
Be it enacted by the Senate and House of Representatives in General Assembly convened:
Section 1. Section 21a-317 of the general statutes is repealed and the following is substituted in lieu thereof (Effective October 1, 2015):
(a) Every practitioner who distributes, administers or dispenses any controlled substance or who proposes to engage in distributing, prescribing, administering or dispensing any controlled substance within this state shall (1) obtain a certificate of registration issued by the Commissioner of Consumer Protection in accordance with the provisions of this chapter, and (2) register for access to the electronic prescription drug monitoring program established pursuant to subsection (j) of section 21a-254. Registration for access to said program shall be in a manner prescribed by said commissioner.
(b) The commissioner shall not issue or renew a license of a practitioner who distributes, administers or dispenses any controlled substance or who proposes to engage in distributing, prescribing, administering or dispensing any controlled substance within this state unless such practitioner has obtained a certificate of registration and registered for access to the electronic prescription drug monitoring program established pursuant to subsection (j) of section 21a-254.
This act shall take effect as follows and shall amend the following sections:
Section 1 October 1, 2015 21a-317
This act shall take effect as follows and shall amend the following sections:
Section 1
October 1, 2015
21a-317
Statement of Purpose:
To make licensing and license renewal for practitioners who distribute, administer or dispense controlled substances contingent on registration in the electronic prescription drug monitoring program.
[Proposed deletions are enclosed in brackets. Proposed additions are indicated by underline, except that when the entire text of a bill or resolution or a section of a bill or resolution is new, it is not underlined.]